Skin barrier in atopic dermatitis;Barreira cutânea na dermatite atópica

Anais Brasileiros de Dermatologia

Volumn 85, Issue 2, 2010, Pages 184-194

  Addor, Flavia Alvim Sant'Anna ^a,b   Aoki, Valeria ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SANTO AMARO   (Brazil)

^c Departamento de Dermatologia da   (Brazil)

Author keywords

Atopic; Dermatitis; Insensible; Keratinocytes; Water loss

Indexed keywords

CERAMIDASE; CERAMIDE 1 PHOSPHATE; GLUCOSYLCERAMIDE; IMMUNOGLOBULIN E; SKIN LIPID; SPHINGOMYELIN;

ANGIOGENESIS; ATOPIC DERMATITIS; DENDRITIC CELL; DRY SKIN; HUMAN; KERATINOCYTE; LAMELLAR BODY; MELANOCYTE; PERMEABILITY BARRIER; REVIEW; SKIN BARRIER; SKIN EPITHELIUM; SKIN PRURITUS; SKIN WATER LOSS; STRATUM CORNEUM; XEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; SKIN;

DERMATITIS, ATOPIC; HUMANS; SKIN;

EID: 77953301977     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962010000200009     Document Type: Review

References (86)

1. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352:2314-24.
2. Hanifin JM. Immunobiochemical aspects of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1989;144:45-7.
3. Sturgill S, Bernard LA. Atopic dermatitis update. Curr Opin Pediatr. 2004;16:396-401.
4. Freiberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith L, Katz SI, et al. Fitzpatrick's Dermatology in general medicine. 6th ed. New York: McGraw Hill; 2003, v. 1. p.1464.
5. Williams HC. On the definition and epidemiology of atopic dermatitis. Dermatol Clin. 1995;13:649-57.
6. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ. 1992;304:873-5.
7. Leung DY, Boguneiwicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113:651-7.
8. Lai-Cheong JE, McGrath JA. Avanços no entendimento da base genética de doenças hereditárias monogênicas da barreira epidérmica: novas pistas para os principais genes que podem estar envolvidos na patogênese da dermatite atópica. An Bras Dermatol. 2006;81:563-68.
9. Serup J. Characterization of contact dermatitis and atopy using bioengineering techniques. A survey. Acta Derm Venereol Suppl (Stockh). 1992;177:14-25.
10. Cristopher E, Kligman AM. Visualization of the cell layers of the stratum corneum. J Invest Dermatol 1964;42:406-7.
11. Blank IH. Cutaneous barriers. J Invest Dermatol. 1965;45:249-56.11
12. Scheuplein RJ, Blank IH. Permeability of he skin. Physiol Rev. 1971;51:702-47.
13. Sato J, Denda M, Chang S, Elias PM, Feingold KR. Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol. 2002;119:900-4. (Pubitemid 35340916)
14. Odland G, Reed T. Epidermis. In: Zelickson A, ed. Ultrastructure of normal and abnormal skin. Philadelphia: Lea & Fabiger; 1967. p.54-75.
15. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and in vitro experimental measurement. Am Inst Chem Eng J. 1975;21:985-96.
16. Johnson ME, Blankschtein D, Langer R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci. 1997;86:1162-72. (Pubitemid 27430923)
17. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permaeability barrier. Adv Lipid Res. 1991;24:1-26.
18. Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4:771-88. (Pubitemid 37452637)
19. Tsai K, Valente NY, Nico MM. Inflammatory peeling skin syndrome studied with electron microscopy. Pediatr Dermatol. 2006;23:488-92. (Pubitemid 44434860)
20. Elias PM. Defensive functions of the stratum corneum. In: Elias PM, Feingold KR. Skin barrier. New York: Taylor & Francis; 2006. p.07
21. Steinert PM, Candi E, Tarcsa E, Marekov LN, Sette M, Paci M, et al. Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein. Cell Death Differ. 1999;6:916-30.
22. Feingold KR. The regulation and role of epidermal lipid synthesis. Adv Lipid Res. 1991;24:57-82.
23. Fartasch M, Williams ML, Elias PM. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol. 1999;135:823-32.
24. Proksch E, Holleran WM, Menon GK, Elias PM, Feingold KR. Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol. 1993;128:473-82.
25. Elias PM. The stratum corneum revisited. J Dermatol. 1996;23:756-8.
26. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol. 1996;106:397-403.
27. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Derm. 1999;10:119-26.
28. Bohme M, Svensson A, Kull I, Wahlgren CF. Hanifin's and Rajka's minor criteria for atopic dermatitis: which do 2-year-olds exhibit? J Am Acad Dermatol. 2000;43 (Pt 1):785-92.
29. Proksch E, Jensen JM, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol. 2003;21:134-44. (Pubitemid 36428984)
30. Linde YW. Dry skin in atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1992;177:9-13.
31. Di Nardo A, Wertz P, Gianetti A, Seidenari S. Ceramide and cholesterol composition of the skin patients with atopic dermatitis. Acta Derm venereol. 1998;78:27-30. (Pubitemid 28103674)
32. Pilgram GS, Vissers DC, Van der Meulen H, Pavel S Lavrijsen SP, Bouwstra JA, Koerten HK. Aberant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichtiosis. J Invest Dermatol. 2001;117:710-7.
33. Murata Y, Ogata,J, Higaki Y, Kawashima M, Yada Y, Higuchi K, et al. Abnormal expression of sphingomielin acylase in atopic dermatitis: an etiologic factor for ceramide deficienency? J Invest Dermatol. 1996;106:1242-9.
34. Diepgen TL, Fartasch M. Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1992;176:13-8.
35. Fartasch M. Epidermal barrier in disorders of the skin. Microsc Res Tech. 1997;38:361-72.
36. Hirao T, Terui T, Takeushi I, Kobaiashi H, Okada M, Takahashi M, et al. Ratio of immature cornified envelopes does not correlate with parakeratosis in inflammatory skin disorders. Exp Dermatol. 2003;12:591-601. (Pubitemid 37270721)
37. Pastore S, Giustizieri ML, Mascia F, Giannetti A, Kaushansky K, Girolomoni G. Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage- colony stimulating factor. J Invest Dermatol. 2000;115:1134-43.
38. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. High expression of sphingomyelin deaclase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol. 2000;115:406-13.
39. Simpson EL, Hanifin JM. Atopic dermatitis. Periodic synopsis. J Am Acad Dermatol. 2005;53:115-28.
40. Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol. 2005;6:215-23.
41. Farwanah H, Raith K, Neubert RH, Wohlrab J. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res. 2005;296:514-21.
42. Lebwohl M, Herrmann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis. 2005;76(6 Suppl):7-12.
43. Hägermark O. Peripheral and central mediators of itch. Skin Pharmacol. 1992;5:1-8.
44. Sehra S, Barbé-Tuana FM, Holbreich M, Mousdicas N, Kaplan MH, Travers JB. Clinical correlations of recent developments in the pathogenesis of atopic dermatitis. An Bras Dermatol. 2008;83:57-73.
45. Arai I, Takaoka A, Hashimoto Y, Honma Y, Koizumi C, Futaki N, et al. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice. Eur J Pharmacol. 2007;556:207-14.
46. Heyer G, Ulmer FJ, Schmitz J, Handwerker HO. Histamine induced itch and alloknessis (icthy skin) in atopic eczema patients and controls. Acta Derm Venereol. 1995;75:348-52.
47. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol. 1995;75:429-33. (Pubitemid 26051887)
48. Pinnagoda J, Tupker RA, Coenraads PJ, Nater JP. Prediction of susceptibility to an irritant response by transepidermal water loss. Contact Dermatitis. 1989;20:341-6. (Pubitemid 19167186)
49. Lee CH, Chuang HY, Shih CC, Jong SB, Chang CH, Yu HS. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol. 2006;154:1100-7.
50. Zink P. [Methods for the determination of mechanical properties of the skin of the human corpse]. Dtsch Z Gesamte Gerichtl Med. 1965;56:349-70.
51. Ridge MD, Wright V. Mechanical properties of skin: a bioengineering study of skin structure. J Appl Physiol. 1966;21:1602-6.
52. Tupker RA. Baseline transepidermal water loss (TEWL) as a prediction of susceptibility to sodium lauryl sulphate. Contact Dermatitis. 1989;20:265-9.
53. Rudolph R, Kownatzki E. Corneometric, sebumetric and TEWL measurements following the cleaning of atopic skin with a urea emulsion versus a detergent cleanser. Contact Dermatitis. 2004;50:354-8. (Pubitemid 39070760)
54. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol. 2001;7:73-7. (Pubitemid 32409572)
55. Yilmaz E, Borchert HH. Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema - an in vivo study. Int J Pharm. 2006;307:232-8. (Pubitemid 41820419)
56. Serup J. A three-hour test for rapid comparison of effects of moisturizers and activeconstituents (urea). Measurement of hydration, scaling and skin surface lipidization by noninvasive techniques. Acta Derm Venereol Suppl (Stockh). 1992;177:29-33.
57. Agache P, Humbert P. Measuring the skin, non-invasive investigations, physiology, normal constants. Berlin Heidelberg: Springer-Verlag; 2004.
58. Kim DW, Park JY, Na GY, Lee SJ, Lee WJ. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. Int J Dermatol. 2006;45:698-701.
59. Holm EA, Wulf HC, Thomassen L, Jemec GB. Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema. J Am Acad Dermatol. 2006;55:772-80.
60. Hon KL, Wong KY, Leung TF, Chow CM, Ng PC. Comparison of skin hydration and evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottinghan Eczema Severity Score and quality of life in patients with atopic dermatitis. Am J Clin Dermatol. 2008; 9:45-50.
61. Gupta J, Grube E, Ericksen MB, Stevenson MD, Lucky AW, Sheth AP, Assa'ad AH, Khurana Hershey GK. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Dermatol. 2008;121:725-730.
62. Nilsson GE. Measurement of water exchange through the skin. Med Biol Eng Comput. 1997;15:209-18.
63. Barel AO, Clarys P. Study of the stratum corneum barrier function by transepidermal water loss measurements: comparison between two commercial instruments: Evaporimeter and Tewameter. Skin Pharmacol. 1995;8:186-95.
64. Miteva M, Richter S, Elsner P, Fluhr JW. Approaches for optimizing the calibration standard of Tewameter TM 300. Exp Dermatol. 2006;15:904-12. (Pubitemid 44473330)
65. Giusti G, Seidenari S. La barriera cutânea nei bambini com dermatite atopica: valutazione instrumentale in 200 pazienti e 45 controlli. Riv Ital Pediatr. 1998;24:954-9.
66. Loffler H, Effendy I. Skin susceptibility of atopic individuals. Contact Dermatitis. 1999;40:239-42.
67. Agner T. Skin susceptibility in unvolved skin of hand eczema patients and healthy controls. Br J Dermatol. 1991;125:140-6.
68. Conti A, Di Nardo A, Seidenari S. No alteration of biophysical parameters in the skin of subjects with respiratory atopy. Dermatology. 1996;192:317-320. (Pubitemid 26238226)
69. Watanabe M, Tagami H, Horii I, Takahashi M, Kligman AM. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol. 1991;127:1689-92.
70. Agner T, Serup J. Comparison of two electrical methods for measurement of skin hydration. An experimental study on irritant patch test reactions. Bioeng Skin. 1988;4:263-9.
71. Fluhr JW, Kuss O, Diepgen T, Lazzerini S, Pelosi A, Gloor M, et al. Testing for irritation with a multifactorial approach: comparison of eight noninvasive measuring techniques on five different irritation types. Br J Dermatol. 2001;145:696-703.
72. Agache P, Mary S, Muret P, Matta AM, Humbert P. Assessment of the water content of the stratum corneum using a sorption-desorption test. Dermatology. 2001;202:308-13.
73. Loden M, Olsson H, Axell T, Linde YW. Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. Br J Dermatol. 1992;126:137-41.
74. Loden M, Andersson AC, Lindberg M. The number of diagnostic features in patients with atopic dermatitis correlates with dryness severity. Acta Derm Venereol. 1998;78:387-8.
75. Werner Y. The water content of the stratum corneum in patients with atopic dermatitis. Measurement with the Corneometer CM 420. Acta Derm Venereol. 1986;66:281-4.
76. Loden M, Andersson AC, Andersson C, Frodin T, Oman H, Lindberg M. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol. 2001;7:209-13.
77. Fuchs M, Schliemann-Willers S, Heinemann C, Elsner P. Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. Contact Dermatitis. 2002;46:290-4. (Pubitemid 34753732)
78. Aoki T. Serum antidiuretic hormone is elevated in relation to the increase in average total body transepidermal water loss in severe atopic dermatitis. Br J Dermatol. 2005;153:359-63. (Pubitemid 41228434)
79. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML. The objective severity assessment of atopic dermatitis score: an objectivemeasure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol. 2003;139:1417-22.
80. Vilaplana J, Coll J, Trullas C, Azon A, Pelejero C. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. Acta Derm Venereol. 1992;72:28-33.
81. Tupker RA, Pinnagoda J, Coenraads PJ, Nater JP. Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis. Br J Dermatol. 1990;123:199-205.
82. Lee CH, Maibach HI. Study of cumulative irritant contact dermatitis in man utilizing open application on subclinically irritated skin. Contact Dermatitis. 1994;30:271-5.
83. Loden M. Biophysical properties of dry atopic skin and normal skin with special reference of skin care products. Acta Derm Venereol Suppl (Stockh). 1995;192:1-48.
84. EEMCO guidance for the assessment of stratum corneum hidration: electrical methods. Berardesca,E; EEMCO (european group for efficacy measurements on cosmetics and other topical products). Skin Res Technol.1997;3:126-32.
85. Seidenari S, Belletti B, Schiavi ME. Skin reactivity to sodium lauryl sulfate in patients with respiratory atopy. J Am Acad Dermatol. 1996;35:47-52.
86. Thune P. Evaluation of the hydration and water holding capacity in atopic skin and so called dry skin. Acta Derm Venereol Suppl (Stockholm). 1989;144:133.